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Abstract
Background: Colonic lymphoma is an uncommon presentation of extranodal lymphoma. Colonic mucosa-
associated lymphoid tissue lymphoma is a different entity from gastric mucosa-associated lymphoid tissue
lymphoma, and very rare. The presentation and management of colonic mucosa-associated lymphoid tissue are
highly variable in the literature.
Case presentation: We report the case of a 59-year-old Taiwanese man who underwent a colonoscopy after a
positive test for fecal occult blood. His past history included hypertension and hyperthyroidism. The colonoscopy
revealed an adenomatous polyp and mucosa-associated lymphoid tissue lymphoma. We successfully performed a
polypectomy and endoscopic mucosal resection. The lymphoma was staged according to the Ann Arbor system
modified by Musshoff as E-I. Our patient showed no lymphoma recurrence over a 3-year follow-up.
Conclusions: Endoscopic mucosal resection for colonic mucosa-associated lymphoid tissue lymphoma without
disseminated disease may be feasible. We successfully used colonoscopic treatment without adjuvant therapy to
treat early-stage pathogen-free colonic mucosa-associated lymphoid tissue lymphoma.
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Background
The gastrointestinal tract is the most common site for
extranodal lymphomas, with the colon being the least in-
volved area [1, 2]. Colon lymphomas account for 15–20 %
of gastrointestinal lymphomas [1], 1.4 % of all non-
Hodgkin’s lymphomas [3], and 1 % of all colorectal malig-
nancies [4]. Mucosa-associated lymphoid tissue (MALT)
lymphoma represents the third most common non-
Hodgkin’s lymphoma [5], and one of the two most com-
mon types of gastrointestinal non-Hodgkin’s lymphoma
[2]. Unlike gastric MALT lymphoma, colonic MALT
lymphoma is very rare. The presentation of colonic MALT
lymphoma is highly variable, and its management is not
clear [6–11]. We treated a male patient with asymptom-
atic colonic MALT lymphoma, which was successfully
resected by colonoscopy.
Case presentation
Our patient was a 59-year-old Taiwanese, well-nourished
man with a history of hypertension for 4 years and
hyperthyroidism for one more year that were well con-
trolled. He was a heavy smoker (1–2 packs per day) for
30 years, and had only quit for a few months. He had re-
ceived a lumbar laminectomy to treat spinal stenosis 6
years previously. He had no relevant family history. He
had developed thyrotoxic exophthalmos 2–3 months
prior to presentation and received steroid pulse therapy
for compressive optic neuropathy. The symptoms were
relieved for 2–3 months after the steroid therapy.
* Correspondence: sumfuchiang@gmail.com
2Division of Colon and Rectal Surgery, Chang Gung Memorial Hospital, 5,
Fu-Hsing Street, Kuei-Shan Hsiang, Tao-Yuan, Linkou, Taiwan
Full list of author information is available at the end of the article
© 2016 Lin et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Lin et al. Journal of Medical Case Reports  (2016) 10:24 
DOI 10.1186/s13256-016-0810-1
He visited our clinic after a positive fecal occult blood
test (132 ng/mL) but reported no change to his bowel
habits. A physical examination revealed bilateral eyes
proptosis and mild obesity. Complete colonoscopy re-
vealed one flat polyp, 0.3 cm in size, located 35 cm from
his anal verge, and another polypoid polyp with a wide
base, 2.0 cm in size with a slightly irregular border, lo-
cated 25 cm from his anal verge. The smaller polyp was
removed by polypectomy. We biopsied the larger polyp
because of its wide base. A pathological examination of
the specimen revealed it was a hyperplastic polyp. We
did not perform an endoscopic ultrasound because we
intended to directly remove the polyp. The polyp was
then removed by endoscopic mucosal resection followed
by clipping (Fig. 1). There were no unexpected events
after the procedure.
A pathological examination of the removed polyps
identified the smaller polyp as adenomatous and the
larger one as a MALT lymphoma, with a polypoid co-
lonic mucosa and atypical lymphoid cells infiltrating
the lamina propria (Fig. 2a). An immunohistochemical
study demonstrated that the larger polyp was positive
for CD20, CD5, and Bcl-2, and negative for CD10 and
cyclin D1 (Fig. 2b). These results supported our diagno-
sis of extranodal marginal zone lymphoma of MALT
type. However, when reviewed by a pathologist, the
margins of the endoscopic mucosal resection specimen
were found to be positive (cauterized margin with
lymphoma cells; Fig. 2c), although it was free on gross
examination.
Our patient was transferred to the hematologist’s
clinic, and further studies revealed no disease dissemin-
ation. A physical examination revealed no palpable
lymph nodes, no petechiae, and no hepatosplenomegaly.
A computed tomography scan revealed no metastatic tu-
mors, nor enlarged lymph nodes. A bone marrow biopsy
of his right iliac bone revealed small aggregates of small
lymphoid cells but an immunohistochemical study did
not suggest any MALT lymphoma involvement. An oto-
rhinolaryngologist found no abnormalities in his ear
drums, nose, oral cavity, nasopharynx, or vocal cord.
The tumor stage was E-I according to the Ann Arbor
staging system modified by Musshoff [12].
Our patient had regular follow-up appointments with
the hematologist and proctologist without any signs of
lymphoma recurrence for 3 years. Two years after his
initial presentation, a colonoscopy revealed a transverse
colon adenoma and a rectal hyperplastic polyp. The pre-
vious site of the MALT lymphoma was free of tumor,
and no other evidence of MALT lymphomas was found.
A polypectomy was performed with no unexpected
events.
According to his history and throughout his clinical
course, our patient had no symptoms or signs of a peptic
ulcer. We did not perform a panendoscopy nor test for
Helicobacter pylori. There were no other symptoms or
signs compatible with autoimmune diseases or viral in-
fection. We did not test for Epstein-Barr virus (EBV).
During the last 2 years, he has had no epigastralgia, no
acid reflux, and no tarry stool.
Fig. 1 Complete colonoscopy revealed a flat polyp located 35 cm from the anal verge (a). Pathology identified it as an adenomatous polyp.
Another 2.0 cm polypoid polyp was found 25 cm from the anal verge (b). It was polypoid with a wide base, slightly irregular border, and an
irregular vascular pattern with mild inflammatory changes. We removed the second lesion (shown in b) by endoscopic mucosal resection (c),
followed by the application of one hemoclip for wound closure (d)
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Discussion
MALT-type lymphoma was first defined by Isaacson and
Wright in 1983 [13]. Colon lymphoma is a rare example
of extranodal lymphoma. Colonic MALT lymphoma is
much rarer than gastric MALT lymphoma, which is
related to H. pylori infection [1, 2, 9]. MALT development
is thought to be related to chronic antigen stimulation [7].
It comprises morphologically heterogeneous small B-cells,
and typically infiltrates the epithelium [14]. Colon MALT
lymphoma might be a more “benign” disease given that
most cases reported in the literature were stage E-I and E-
II diseases without dissemination [6–11].
The most well-known gastrointestinal lymphoma is gas-
tric MALT lymphoma. Gastric MALT lymphoma has a
strong predisposing factor, H. pylori infection. The preva-
lence of H. pylori infection is as high as 80 % in patients
with gastric MALT lymphoma [15, 16]. However, not all
patients are responsive to H. pylori eradication [17, 18].
Furthermore, the recurrence of gastric MALT lymphoma
is accompanied by H. pylori infection in only 0–57 % of
patients [17, 19]. Asano et al. reviewed H. pylori-negative
gastric MALT lymphomas and suggested that possible
mechanisms include antibiotic eradication for non-H. pyl-
ori bacteria and the immunomodulatory effect of clari-
thromycin [20].
Other associated diseases, such as EBV infection and
autoimmune diseases, have also been reported in the
literature [21]. Kaneko et al. reported the resemblance be-
tween tonsil MALT lymphoma and EBV-related tonsillar
hyperplasia [21]. These two diseases can only be differenti-
ated by immunohistochemical studies. MALT lymphomas
of sites other than the stomach have also been reported.
They include lung [22], tonsil [21], and ocular adnexa
[23]. Most of them these lymphomas had a benign or pre-
malignant nature with an excellent prognosis [22, 23].
Unlike gastric MALT lymphoma, colon MALT lymph-
oma does not have any obvious predisposing factors. Al-
though chronic antigen stimulation is a hypothetical
etiology [7], it was not present in most reported colon
MALT lymphomas. Several cases with MALT lymphoma
received and responded to H. pylori eradication [7, 10]. Our
patient had a history of hyperthyroidism and exophthalmos,
but associations between other diseases and colon MALT
lymphoma had not been reported in the literature until 2–3
years ago. Jain et al. reported a MALT lymphoma of the
cecum presenting as an acute bowel obstruction; however,
no H. pylori nor other etiologies could be identified [24].
Terada reported the case of an 18-year-old man with a 2-
year history of ulcerative colitis who developed MALT
lymphoma [25]. His diagnosis was made by colonoscopic
biopsy, and he only received treatment for his ulcerative
colitis after that [25].
The presentation and management of colonic MALT
lymphoma are still highly variable. The symptoms in-
clude a positive test for fecal occult blood, constipation,
abdominal pain, gastro-intestinal bleeding, and tenes-
mus, or it may be asymptomatic [6–11]. Management
includes local resection, colectomy, H. pylori eradication,
chemotherapy, and radiotherapy [6–8, 10, 11]. To the
Fig. 2 Pathology of the larger polypoid polyp revealed polypoid
colonic mucosa with atypical lymphoid cells infiltrating the lamina
propria (a). An immunohistochemical study found that the specimen
was positive for CD20, CD5, and Bcl-2, and negative for CD10 and
cyclin D1, which supported the diagnosis of extranodal marginal
zone lymphoma of mucosa-associated lymphoid tissue lymphoma
type (b). The resected specimen is positive for lymphoma cells,
which are present at the cauterized margin (left side of the figure;
hematoxylin and eosin stain, 100×) (c)
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best of our knowledge, our patient’s case is the first re-
port of successful management by colonoscopy for
MALT lymphoma. No antibiotic eradication was applied.
Our patient has one of the longest follow-up times with-
out recurrence (3 years) reported in the literature [6].
However, the rarity of colon MALT lymphomas means
that more cases are required for comparison.
Conclusion
Although more and more MALT lymphomas have been
reported, colon involvement is still relatively rare. We
report the case of a patient with a colonic MALT lymph-
oma with previous hyperthyroidism. Our patient was
asymptomatic and underwent endoscopic mucosal resec-
tion without antibiotic eradication for a stage E-I tumor.
He attended regular follow-up appointments without
lymphoma recurrence for 3 years. A “wait and see” policy
for resectable stage E-I colonic MALT lymphoma without
pathogens seems to be a reasonable course of action.
However, more studies about standard management for
the disease are needed.
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